Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.

Elliott PM, Anastasakis A, Asimaki A, Basso C, Bauce B, Brooke MA, Calkins H, Corrado D, Duru F, Green KJ, Judge DP, Kelsell D, Lambiase PD, McKenna WJ, Pilichou K, Protonotarios A, Saffitz JE, Syrris P, Tandri H, Te Riele A, Thiene G, Tsatsopoulou A, van Tintelen JP.

Eur J Heart Fail. 2019 Aug;21(8):955-964. doi: 10.1002/ejhf.1534. Epub 2019 Jun 18.

2.

Myocardial Inflammation in Brugada Syndrome.

Miles C, Asimaki A, Behr ER, Sheppard MN.

J Am Coll Cardiol. 2019 Mar 26;73(11):1369-1370. doi: 10.1016/j.jacc.2018.12.058. No abstract available.

PMID:
30898219
3.

Reduced desmoplakin immunofluorescence signal in arrhythmogenic cardiomyopathy with epicardial right ventricular outflow tract tachycardia.

Rosset S, Domingo AM, Asimaki A, Graf D, Metzger J, Schwitter J, Rotman S, Pruvot E.

HeartRhythm Case Rep. 2018 Jul 9;5(2):57-62. doi: 10.1016/j.hrcr.2018.06.013. eCollection 2019 Feb. No abstract available.

4.

Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.

Te Rijdt WP, Asimaki A, Jongbloed JDH, Hoorntje ET, Lazzarini E, van der Zwaag PA, de Boer RA, van Tintelen JP, Saffitz JE, van den Berg MP, Suurmeijer AJH.

Cardiovasc Pathol. 2019 May - Jun;40:2-6. doi: 10.1016/j.carpath.2018.12.006. Epub 2018 Dec 21.

PMID:
30763825
5.

Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy.

Miles C, Finocchiaro G, Papadakis M, Gray B, Westaby J, Ensam B, Basu J, Parry-Williams G, Papatheodorou E, Paterson C, Malhotra A, Robertus JL, Ware JS, Cook SA, Asimaki A, Witney A, Ster IC, Tome M, Sharma S, Behr ER, Sheppard MN.

Circulation. 2019 Apr 9;139(15):1786-1797. doi: 10.1161/CIRCULATIONAHA.118.037230.

6.

Malignant interventricular liposarcoma.

Tourmousoglou C, Kallifatidis A, Karamitsos T, Nikoloudakis N, Asimaki A, Pitsis A.

Hellenic J Cardiol. 2019 Jan 23. pii: S1109-9666(18)30519-0. doi: 10.1016/j.hjc.2019.01.011. [Epub ahead of print] No abstract available.

7.

Homozygous Truncating Variant in PKP2 Causes Hypoplastic Left Heart Syndrome.

Verhagen JMA, van den Born M, Kurul S, Asimaki A, van de Laar IMBH, Frohn-Mulder IME, Kammeraad JAE, Yap SC, Bartelings MM, van Slegtenhorst MA, von der Thüsen JH, Wessels MW.

Circ Genom Precis Med. 2018 Dec;11(12):e002397. doi: 10.1161/CIRCGEN.118.002397. No abstract available.

PMID:
30562116
8.

Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell-Cell Adhesion Structures.

Begay RL, Graw SL, Sinagra G, Asimaki A, Rowland TJ, Slavov DB, Gowan K, Jones KL, Brun F, Merlo M, Miani D, Sweet M, Devaraj K, Wartchow EP, Gigli M, Puggia I, Salcedo EE, Garrity DM, Ambardekar AV, Buttrick P, Reece TB, Bristow MR, Saffitz JE, Mestroni L, Taylor MRG.

JACC Clin Electrophysiol. 2018 Apr;4(4):504-514. doi: 10.1016/j.jacep.2017.12.003. Epub 2018 Feb 2.

9.

Gene promoter methylation and protein expression of BRMS1 in uterine cervix in relation to high-risk human papilloma virus infection and cancer.

Panagopoulou M, Lambropoulou M, Balgkouranidou I, Nena E, Karaglani M, Nicolaidou C, Asimaki A, Konstantinidis T, Constantinidis TC, Kolios G, Kakolyris S, Agorastos T, Chatzaki E.

Tumour Biol. 2017 Apr;39(4):1010428317697557. doi: 10.1177/1010428317697557.

PMID:
28381193
10.

Left Ventricular Cardiac Hemangioma.

Tourmousoglou C, Nikoloudakis N, Kelpis T, Tsotsolis N, Ninios V, Kallifatidis A, Ninios E, Theofilogiannakos EK, Thoma M, Asimaki A, Pitsis A.

Am J Med. 2017 Aug;130(8):e337-e339. doi: 10.1016/j.amjmed.2017.02.043. Epub 2017 Apr 2. No abstract available.

PMID:
28373114
11.

MY APPROACH to the patient with arrhythmogenic right ventricular cardiomyopathy (ARVC).

Asimaki A.

Trends Cardiovasc Med. 2017 May;27(4):293. doi: 10.1016/j.tcm.2016.09.008. Epub 2016 Nov 2. No abstract available.

PMID:
28185710
12.

Development of dilated cardiomyopathy and impaired calcium homeostasis with cardiac-specific deletion of ESRRβ.

Rowe GC, Asimaki A, Graham EL, Martin KD, Margulies KB, Das S, Saffitz J, Arany Z.

Am J Physiol Heart Circ Physiol. 2017 Apr 1;312(4):H662-H671. doi: 10.1152/ajpheart.00446.2016. Epub 2017 Jan 27.

13.

Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy.

Chelko SP, Asimaki A, Andersen P, Bedja D, Amat-Alarcon N, DeMazumder D, Jasti R, MacRae CA, Leber R, Kleber AG, Saffitz JE, Judge DP.

JCI Insight. 2016 Apr 21;1(5). pii: 85923. doi: 10.1172/jci.insight.85923.

14.

Cardiac sarcoidosis with severe involvement of the right ventricle: a case report.

Siqueira WC, da Cruz SG, Asimaki A, Saffitz JE, Moreira Mda C, Brasileiro G Jr, Rocha LO.

Autops Case Rep. 2015 Dec 30;5(4):53-63. doi: 10.4322/acr.2015.030. eCollection 2015 Oct-Dec.

15.

Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells.

Asimaki A, Protonotarios A, James CA, Chelko SP, Tichnell C, Murray B, Tsatsopoulou A, Anastasakis A, te Riele A, Kléber AG, Judge DP, Calkins H, Saffitz JE.

Circ Arrhythm Electrophysiol. 2016 Feb;9(2):e003688. doi: 10.1161/CIRCEP.115.003688.

16.

Biallelic Truncating Mutations in ALPK3 Cause Severe Pediatric Cardiomyopathy.

Almomani R, Verhagen JM, Herkert JC, Brosens E, van Spaendonck-Zwarts KY, Asimaki A, van der Zwaag PA, Frohn-Mulder IM, Bertoli-Avella AM, Boven LG, van Slegtenhorst MA, van der Smagt JJ, van IJcken WF, Timmer B, van Stuijvenberg M, Verdijk RM, Saffitz JE, du Plessis FA, Michels M, Hofstra RM, Sinke RJ, van Tintelen JP, Wessels MW, Jongbloed JD, van de Laar IM.

J Am Coll Cardiol. 2016 Feb 9;67(5):515-25. doi: 10.1016/j.jacc.2015.10.093.

17.

Pathogenesis of Arrhythmogenic Cardiomyopathy.

Asimaki A, Kleber AG, Saffitz JE.

Can J Cardiol. 2015 Nov;31(11):1313-24. doi: 10.1016/j.cjca.2015.04.012. Epub 2015 Apr 24. Review.

18.

Arrhythmogenic Cardiomyopathy - New Insights into Disease Mechanisms and Drug Discovery.

Asimaki A, Kléber AG, MacRae CA, Saffitz JE.

Prog Pediatr Cardiol. 2014 Dec 1;37(1-2):3-7.

19.

Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.

Hariharan V, Asimaki A, Michaelson JE, Plovie E, MacRae CA, Saffitz JE, Huang H.

Cardiovasc Res. 2014 Nov 1;104(2):280-9. doi: 10.1093/cvr/cvu212. Epub 2014 Sep 24.

20.

Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy.

Asimaki A, Kapoor S, Plovie E, Karin Arndt A, Adams E, Liu Z, James CA, Judge DP, Calkins H, Churko J, Wu JC, MacRae CA, Kléber AG, Saffitz JE.

Sci Transl Med. 2014 Jun 11;6(240):240ra74. doi: 10.1126/scitranslmed.3008008. Erratum in: Sci Transl Med. 2014 Nov 5;6(261):261er6.

21.

Persistent lone atrial fibrillation: clinicopathologic study of 19 cases.

Corradi D, Callegari S, Manotti L, Ferrara D, Goldoni M, Alinovi R, Pinelli S, Mozzoni P, Andreoli R, Asimaki A, Pozzoli A, Becchi G, Mutti A, Benussi S, Saffitz JE, Alfieri O.

Heart Rhythm. 2014 Jul;11(7):1250-8. doi: 10.1016/j.hrthm.2014.02.008. Epub 2014 Feb 18.

PMID:
24560692
22.

Remodeling of cell-cell junctions in arrhythmogenic cardiomyopathy.

Asimaki A, Saffitz JE.

Cell Commun Adhes. 2014 Feb;21(1):13-23. doi: 10.3109/15419061.2013.876016. Review.

23.

Reduced plakoglobin immunoreactivity in arrhythmogenic cardiomyopathy: methodological considerations.

Noorman M, Hakim S, Asimaki A, Vreeker A, van Rijen HV, van der Heyden MA, de Jonge N, de Weger RA, Hauer RN, Saffitz JE, van Veen TA.

Cardiovasc Pathol. 2013 Sep-Oct;22(5):314-8. doi: 10.1016/j.carpath.2013.04.002. Epub 2013 May 17.

PMID:
23688911
24.

Expression of cathepsin K and tartrate-resistant acid phosphatase is not confined to osteoclasts but is a general feature of multinucleated giant cells: systematic analysis.

Park JK, Rosen A, Saffitz JE, Asimaki A, Litovsky SH, Mackey-Bojack SM, Halushka MK.

Rheumatology (Oxford). 2013 Aug;52(8):1529-33. doi: 10.1093/rheumatology/ket184. Epub 2013 May 14.

PMID:
23674817
25.

Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy.

Noorman M, Hakim S, Kessler E, Groeneweg JA, Cox MG, Asimaki A, van Rijen HV, van Stuijvenberg L, Chkourko H, van der Heyden MA, Vos MA, de Jonge N, van der Smagt JJ, Dooijes D, Vink A, de Weger RA, Varro A, de Bakker JM, Saffitz JE, Hund TJ, Mohler PJ, Delmar M, Hauer RN, van Veen TA.

Heart Rhythm. 2013 Mar;10(3):412-9. doi: 10.1016/j.hrthm.2012.11.018. Epub 2012 Nov 23.

26.

End stage of arrhythmogenic cardiomyopathy with severe involvement of the interventricular septum.

Noorman M, Groeneweg JA, Asimaki A, Rizzo S, Papegaaij M, van Stuijvenberg L, de Jonge N, Dooijes D, Basso C, Saffitz JE, van Veen TA, Vink A, Hauer RN.

Heart Rhythm. 2013 Feb;10(2):283-9. doi: 10.1016/j.hrthm.2012.10.029. Epub 2012 Oct 18.

PMID:
23085127
27.

Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy.

van der Zwaag PA, van Rijsingen IA, Asimaki A, Jongbloed JD, van Veldhuisen DJ, Wiesfeld AC, Cox MG, van Lochem LT, de Boer RA, Hofstra RM, Christiaans I, van Spaendonck-Zwarts KY, Lekanne dit Deprez RH, Judge DP, Calkins H, Suurmeijer AJ, Hauer RN, Saffitz JE, Wilde AA, van den Berg MP, van Tintelen JP.

Eur J Heart Fail. 2012 Nov;14(11):1199-207. doi: 10.1093/eurjhf/hfs119. Epub 2012 Jul 20.

28.

Electrical coupling and propagation in engineered ventricular myocardium with heterogeneous expression of connexin43.

Beauchamp P, Desplantez T, McCain ML, Li W, Asimaki A, Rigoli G, Parker KK, Saffitz JE, Kleber AG.

Circ Res. 2012 May 25;110(11):1445-53. doi: 10.1161/CIRCRESAHA.111.259705. Epub 2012 Apr 19.

29.

BIN1: a new biomarker to track ARVC?

Asimaki A.

Heart Rhythm. 2012 Jun;9(6):968-9. doi: 10.1016/j.hrthm.2012.02.025. Epub 2012 Mar 3. No abstract available.

PMID:
22387380
30.

Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study.

Gomes J, Finlay M, Ahmed AK, Ciaccio EJ, Asimaki A, Saffitz JE, Quarta G, Nobles M, Syrris P, Chaubey S, McKenna WJ, Tinker A, Lambiase PD.

Eur Heart J. 2012 Aug;33(15):1942-53. doi: 10.1093/eurheartj/ehr472. Epub 2012 Jan 11.

31.

Connexin43 mutation causes heterogeneous gap junction loss and sudden infant death.

Van Norstrand DW, Asimaki A, Rubinos C, Dolmatova E, Srinivas M, Tester DJ, Saffitz JE, Duffy HS, Ackerman MJ.

Circulation. 2012 Jan 24;125(3):474-81. doi: 10.1161/CIRCULATIONAHA.111.057224. Epub 2011 Dec 16.

32.

Gap junctions and arrhythmogenic cardiomyopathy.

Asimaki A, Saffitz JE.

Heart Rhythm. 2012 Jun;9(6):992-5. doi: 10.1016/j.hrthm.2011.11.024. Epub 2011 Nov 16. Review. No abstract available.

33.

Molecular changes in the heart of a severe case of arrhythmogenic right ventricular cardiomyopathy caused by a desmoglein-2 null allele.

Gehmlich K, Syrris P, Reimann M, Asimaki A, Ehler E, Evans A, Quarta G, Pantazis A, Saffitz JE, McKenna WJ.

Cardiovasc Pathol. 2012 Jul-Aug;21(4):275-82. doi: 10.1016/j.carpath.2011.09.005. Epub 2011 Oct 27.

PMID:
22036071
34.

Arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Avramides D, Protonotarios N, Asimaki A, Matsakas E.

Hellenic J Cardiol. 2011 Sep-Oct;52(5):452-61.

35.

Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.

Asimaki A, Tandri H, Duffy ER, Winterfield JR, Mackey-Bojack S, Picken MM, Cooper LT, Wilber DJ, Marcus FI, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, Stevenson WG, McKenna WJ, Gautam S, Remick DG, Calkins H, Saffitz JE.

Circ Arrhythm Electrophysiol. 2011 Oct;4(5):743-52. doi: 10.1161/CIRCEP.111.964890. Epub 2011 Aug 22.

36.

[Left dominant arrhythmogenic cardiomyopathy caused by a novel nonsense mutation in desmoplakin].

Navarro-Manchón J, Fernández E, Igual B, Asimaki A, Syrris P, Osca J, Salvador A, Zorio E.

Rev Esp Cardiol. 2011 Jun;64(6):530-4. doi: 10.1016/j.recesp.2010.10.020. Epub 2011 Mar 31. Spanish.

37.

Arrhythmogenic right ventricular cardiomyopathy/dysplasia on the basis of the revised diagnostic criteria in affected families with desmosomal mutations.

Protonotarios N, Anastasakis A, Antoniades L, Chlouverakis G, Syrris P, Basso C, Asimaki A, Theopistou A, Stefanadis C, Thiene G, McKenna WJ, Tsatsopoulou A.

Eur Heart J. 2011 May;32(9):1097-104. doi: 10.1093/eurheartj/ehr043. Epub 2011 Feb 22.

38.

The role of endomyocardial biopsy in ARVC: looking beyond histology in search of new diagnostic markers.

Asimaki A, Saffitz JE.

J Cardiovasc Electrophysiol. 2011 Jan;22(1):111-7. doi: 10.1111/j.1540-8167.2010.01960.x. Epub 2010 Nov 18.

39.

A novel desmocollin-2 mutation reveals insights into the molecular link between desmosomes and gap junctions.

Gehmlich K, Lambiase PD, Asimaki A, Ciaccio EJ, Ehler E, Syrris P, Saffitz JE, McKenna WJ.

Heart Rhythm. 2011 May;8(5):711-8. doi: 10.1016/j.hrthm.2011.01.010. Epub 2011 Jan 7.

40.

Mechanistic insights into arrhythmogenic right ventricular cardiomyopathy caused by desmocollin-2 mutations.

Gehmlich K, Syrris P, Peskett E, Evans A, Ehler E, Asimaki A, Anastasakis A, Tsatsopoulou A, Vouliotis AI, Stefanadis C, Saffitz JE, Protonotarios N, McKenna WJ.

Cardiovasc Res. 2011 Apr 1;90(1):77-87. doi: 10.1093/cvr/cvq353. Epub 2010 Nov 9.

41.

Novel missense mutations in exon 15 of desmoglein-2: role of the intracellular cadherin segment in arrhythmogenic right ventricular cardiomyopathy?

Gehmlich K, Asimaki A, Cahill TJ, Ehler E, Syrris P, Zachara E, Re F, Avella A, Monserrat L, Saffitz JE, McKenna WJ.

Heart Rhythm. 2010 Oct;7(10):1446-53. doi: 10.1016/j.hrthm.2010.08.007. Epub 2010 Aug 11.

42.

Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks.

Otten E, Asimaki A, Maass A, van Langen IM, van der Wal A, de Jonge N, van den Berg MP, Saffitz JE, Wilde AA, Jongbloed JD, van Tintelen JP.

Heart Rhythm. 2010 Aug;7(8):1058-64. doi: 10.1016/j.hrthm.2010.04.023. Epub 2010 Apr 24.

PMID:
20423733
43.

Arrhythmogenic right ventricular cardiomyopathy: new insights into mechanisms of disease.

Saffitz JE, Asimaki A, Huang H.

Cardiovasc Pathol. 2010 May-Jun;19(3):166-70. doi: 10.1016/j.carpath.2009.10.006. Epub 2010 Jan 6. Review.

PMID:
20051321
44.

Arrhythmogenic right ventricular cardiomyopathy: new insights into disease mechanisms and diagnosis.

Saffitz JE, Asimaki A, Huang H.

J Investig Med. 2009 Dec;57(8):861-4. doi: 10.2310/JIM.0b013e3181c5e631. Review.

PMID:
19952894
45.

Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene.

van Tintelen JP, Van Gelder IC, Asimaki A, Suurmeijer AJ, Wiesfeld AC, Jongbloed JD, van den Wijngaard A, Kuks JB, van Spaendonck-Zwarts KY, Notermans N, Boven L, van den Heuvel F, Veenstra-Knol HE, Saffitz JE, Hofstra RM, van den Berg MP.

Heart Rhythm. 2009 Nov;6(11):1574-83. doi: 10.1016/j.hrthm.2009.07.041. Epub 2009 Jul 28.

PMID:
19879535
46.

Imaging of ectopic intrathoracic multinodular goiter with pathologic correlation: a case report.

Pilavaki M, Kostopoulos G, Asimaki A, Papachristodoulou A, Papaemanouil S, Palladas P.

Cases J. 2009 Jul 16;2:8554. doi: 10.4076/1757-1626-2-8554.

47.

Asymptomatic papillary fibroelastoma of the aortic valve in a young woman - a case report.

Parthenakis F, Nyktari E, Patrianakos A, Pitsis A, Asimaki A, Vardas P.

Cardiovasc Ultrasound. 2009 Sep 2;7:43. doi: 10.1186/1476-7120-7-43.

48.

Prolonged RV endocardial activation duration: a novel marker of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Tandri H, Asimaki A, Abraham T, Dalal D, Tops L, Jain R, Saffitz JE, Judge DP, Russell SD, Halushka M, Bluemke DA, Kass DA, Calkins H.

Heart Rhythm. 2009 Jun;6(6):769-75. doi: 10.1016/j.hrthm.2009.02.031. Epub 2009 Feb 24.

49.

A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy.

Asimaki A, Tandri H, Huang H, Halushka MK, Gautam S, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, McKenna WJ, Calkins H, Saffitz JE.

N Engl J Med. 2009 Mar 12;360(11):1075-84. doi: 10.1056/NEJMoa0808138.

50.

Unique epidermolytic bullous dermatosis with associated lethal cardiomyopathy related to novel desmoplakin mutations.

Asimaki A, Syrris P, Ward D, Guereta LG, Saffitz JE, McKenna WJ.

J Cutan Pathol. 2009 May;36(5):553-9. doi: 10.1111/j.1600-0560.2008.01112.x. Epub 2008 Oct 29.

PMID:
19178614

Supplemental Content

Loading ...
Support Center